1. Home
  2. ACV vs BIOA Comparison

ACV vs BIOA Comparison

Compare ACV & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtus Diversified Income & Convertible Fund of Beneficial Interest

ACV

Virtus Diversified Income & Convertible Fund of Beneficial Interest

N/A

Current Price

$21.03

Market Cap

246.2M

Sector

Finance

ML Signal

N/A

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

N/A

Current Price

$4.29

Market Cap

255.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ACV
BIOA
Founded
2015
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
246.2M
255.6M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
ACV
BIOA
Price
$21.03
$4.29
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
★ $28.44
AVG Volume (30 Days)
28.8K
★ 640.4K
Earning Date
01-01-0001
11-05-2026
Dividend Yield
★ 9.20%
N/A
EPS Growth
N/A
★ 66.21
EPS
★ N/A
N/A
Revenue
N/A
★ $8,995,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$114.74
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.41
$4.46
52 Week High
$29.04
$25.96

Technical Indicators

Market Signals
Indicator
ACV
BIOA
Relative Strength Index (RSI) 24.10 26.73
Support Level N/A N/A
Resistance Level $28.27 $6.30
Average True Range (ATR) 0.57 0.45
MACD -0.16 -0.06
Stochastic Oscillator 0.64 0.49

Price Performance

Historical Comparison
ACV
BIOA

About ACV Virtus Diversified Income & Convertible Fund of Beneficial Interest

Virtus AllianzGI Diversified Income & Convertible Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. It invests in a diversified portfolio of convertible securities, income-producing equity securities, and income-producing debt and other instruments of varying maturities, of which a majority of the managed assets are invested in convertibles.

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

Share on Social Networks: